In a CD68-associated pan-cancer analysis, CD68 was found to be highly expressed in many cancer types and associated with immune infiltration in tumor mutation burden (TMB), microsatellite instability (MSI), and TME, which may become a new immune checkpoint in future tumor immunotherapy42. The gene discussed is CD68; the disease is neoplasm.